ERLEVA 150MG TAB is a prescription medication used to treat certain types of non-small cell lung cancer (NSCLC) and pancreatic cancer.
Composition:
Each tablet of ERLEVA 150MG TAB contains 150mg of erlotinib.
Mechanism of Action:
Erlotinib works by:
- Inhibiting the action of epidermal growth factor receptor (EGFR), a protein that helps regulate cell growth and division
- Blocking the signaling pathways that allow cancer cells to grow and multiply
- Causing cancer cells to die or stop growing
Uses:
ERLEVA 150MG TAB is used to treat:
- NSCLC that has progressed or recurred after previous treatment, and whose tumors have a specific genetic mutation in the EGFR gene
- Pancreatic cancer in combination with gemcitabine (Gemzar) in patients who have not received prior chemotherapy
Dosage:
The recommended dosage of ERLEVA 150MG TAB is:
- 150mg taken orally once daily, in combination with gemcitabine, for pancreatic cancer
- 150mg taken orally once daily, in patients with NSCLC who have a specific genetic mutation in the EGFR gene
Side Effects:
Common side effects of ERLEVA 150MG TAB include:
- Rash
- Diarrhea
- Nausea and vomiting
- Fatigue
- Increased risk of infections
- Skin lesions
- Increased risk of respiratory infections
Recommendation:
ERLEVA 150MG TAB is recommended for patients who have not responded to previous treatment for their cancer. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take ERLEVA 150MG TAB if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking ERLEVA 150MG TAB.
Some common brands of erlotinib include:
- Tarceva (Roche)
- Erlotinib (Roche)
Please note that ERLEVA 150MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.
It’s worth noting that ERLEVA 150MG TAB is a targeted therapy, meaning it is designed to specifically target the EGFR pathway in cancer cells. This can be an effective treatment option for patients with certain types of cancer, as it can help to slow or stop the growth of cancer cells.
Reviews
There are no reviews yet.